Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Johnson and Johnson
Express Scripts

Generated: October 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,548,084

« Back to Dashboard

Which drugs does patent 6,548,084 protect, and when does it expire?

Patent 6,548,084 protects PAXIL CR and is included in one NDA. There have been two Paragraph IV challenges on Paxil CR.

Protection for PAXIL CR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 6,548,084

Title: Controlled release compositions
Abstract:A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
Inventor(s): Leonard; Graham Stanley (St Albans, GB), Elder; David Philip (Hertford, GB)
Assignee: SmithKline Beecham plc (GB)
Application Number:09/391,796
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Composition; Compound; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Apotex Technologies
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-001Feb 16, 1999ABRXYesNo► Subscribe► SubscribeY
Apotex Technologies
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-002Feb 16, 1999ABRXYesNo► Subscribe► SubscribeY
Apotex Technologies
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-003Dec 6, 2000ABRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,548,084

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9514842Jul 20, 1995

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus